BioLineRx Ltd. Comprehensive Income Attributable To Noncontrolling Interests
BioLineRx Ltd. (BLRX) reported Comprehensive Income Attributable To Noncontrolling Interests of -$851.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests · last filed 2026-03-23
| Period end | Comprehensive Income Attributable To Noncontrolling Interests 12 month |
|---|---|
| 2025-12-31 | -$851.00K 20-F · filed 2026-03-23 |
| 2024-12-31 | $0.00 20-F · filed 2026-03-23 |
| 2023-12-31 | $0.00 20-F · filed 2026-03-23 |